BioSpace News Archive

Drug Development

Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients

Memo Therapeutics AG, a late-stage biotech company developing best-in-class therapeutic antibodies, announced the closing of a CHF25 million Series C financing led by Pureos Bioventures.

November 2, 2023
·
3 min read
Business

Orexo Q3 2023 Interim Report

The MODIA® study didn’t meet the primary end-points, but showed high rates of treatment response in both study arms, with no adverse events associated with the use of MODIA.

November 2, 2023
·
3 min read
AlzeCure Presents at Redeye Life Science Day on November 23

AlzeCure Pharma AB announced that the company is participating at Redeye Life Science Day 2023 on November 23 at 11:30 CET, where CEO Martin Jönsson will present and answer questions about the latest developments and the company’s plans going forward.

November 2, 2023
·
2 min read
Business

Constructive Bio Strengthens Management Team and Board of Directors with Key Appointments to Accelerate Synthetic Genomics to Innovate Biologic Therapies

Constructive Bio, a biotech that rewrites genomes to create biomolecules that were previously unimaginable, announces the appointment of Dr Paul Wallace as Chief Business Officer, and Rahul K Dhanda as a Non-Executive Director with immediate effect.

November 2, 2023
·
4 min read
Policy

Chipscreen’s New Drug Candidate CS32582 Capsules Approved for Clinical Treatment of Psoriasis

Shenzhen Chipscreen Biosciences Co., Ltd. received the “Drug Clinical Trial Approval Notice” issued by the National Medical Products Administration through its wholly-owned subsidiary, Chengdu Chipscreen Pharmaceutical Co., Ltd.

November 2, 2023
·
4 min read
Philips and County Durham and Darlington NHS Foundation Trust collaborate on a sustainability blueprint to reduce carbon emissions and waste

Royal Philips, a global leader in health technology and County Durham and Darlington NHS Foundation Trust, one of the largest integrated care providers in England, announced the results of a comprehensive 360 sustainability analysis.

November 2, 2023
·
5 min read
Business

Dentsply Sirona Reports Third Quarter 2023 Results

DENTSPLY SIRONA Inc. announced its financial results for the third quarter of 2023.

November 2, 2023
·
22 min read
BioForest

Renaissance BioScience and Certis Belchim enter partnership for innovative biopesticide development

Renaissance BioScience is pleased to announce that it has signed a joint development agreement with Certis Belchim, a global leader in the development of crop-protecting biocontrol agents that combat agricultural pests.

November 2, 2023
·
3 min read
Business

The Cigna Group Reports Strong Third Quarter 2023 Results, Raises 2023 Adjusted EPS, Revenue, and Cash Flow Outlook

Global health company The Cigna Group reported strong third quarter results reflecting revenue and earnings growth across its diversified portfolio of businesses.

November 2, 2023
·
27 min read
Pharm Country

Cambrex Announces Sale of Drug Product Business Unit

Cambrex, a leading global contract development and manufacturing organization, has completed the sale of its Drug Product Business Unit to Wilmington, Delaware based Noramco.

November 2, 2023
·
1 min read